Avanir Pharmaceuticals rallied on above-average volume after it said a higher dosage of its leading drug candidate met the primary endpoint of a Phase III trial.
10:52AM 10/09/09
Early Movers: Pump Up the Volume
Several small-cap stocks were poised to move on above-average volume during Wednesday's session.
08:51AM 10/07/09
Biotech Calendar: Key Dates and Events
A quick and dirty guide to important biotech events for October.
09:55AM 09/30/09
Krawcheck Buys $1 Millon of BofA
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
01:35PM 08/14/09
Here's what stood out in the market today.
05:18PM 08/11/09
Are Financials "Trading On Fumes"?
Gregg Greenberg breaks down today's market action. Guests include Richard Suttmeier, ValuEngine.com Chief Market Strategist, TheStreet.com Under $10 portfolio manager David Peltier and RealMoney.com contributor Dan Dicker.
05:11PM 08/11/09
Stock Wrap: The Real Story, August 11
NEW YORK (TheStreet) -- A successful Treasury auction wasn't enough to cheer the market Tuesday as financials drooped and Wall Street focused on the Fed's policy-making meeting.
05:09PM 08/11/09
Avanir Jumps on Study Results (Update)
Avanir Pharmaceuticals says phase III tests show that its drug Zenvia can safely reduce the effects of a neurological disorder.
04:52PM 08/11/09
Stocks Under $10 portfolio manager David Peltier discusses twoactively-traded names in his universe.
02:35PM 08/11/09
Director Sells $6.4M Worth of EV3
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:43AM 08/04/09
Must-See Charts: Stocks Making New Highs
These stocks are at or near new highs and could be setting up to move even higher.
02:23PM 06/29/09
Small-Cap Speculators Stay Lively (RealMoney.com $)
Take profits into strength, because a reversal could come quickly.
12:14PM 06/09/09
Friday's Health Winners & Losers
Sanofi-Aventis climbs on an extended FDA approval.
11:39PM 08/06/07



Connect with TheStreet